Loss of ETHE1, a Mitochondrial Dioxygenase, Causes Fatal Sulfide Toxicity in Ethylmalonic Encephalopathy
Overview
Molecular Biology
Authors
Affiliations
Ethylmalonic encephalopathy is an autosomal recessive, invariably fatal disorder characterized by early-onset encephalopathy, microangiopathy, chronic diarrhea, defective cytochrome c oxidase (COX) in muscle and brain, high concentrations of C4 and C5 acylcarnitines in blood and high excretion of ethylmalonic acid in urine. ETHE1, a gene encoding a beta-lactamase-like, iron-coordinating metalloprotein, is mutated in ethylmalonic encephalopathy. In bacteria, ETHE1-like sequences are in the same operon of, or fused with, orthologs of TST, the gene encoding rhodanese, a sulfurtransferase. In eukaryotes, both ETHE1 and rhodanese are located within the mitochondrial matrix. We created a Ethe1(-/-) mouse that showed the cardinal features of ethylmalonic encephalopathy. We found that thiosulfate was excreted in massive amounts in urine of both Ethe1(-/-) mice and humans with ethylmalonic encephalopathy. High thiosulfate and sulfide concentrations were present in Ethe1(-/-) mouse tissues. Sulfide is a powerful inhibitor of COX and short-chain fatty acid oxidation, with vasoactive and vasotoxic effects that explain the microangiopathy in ethylmalonic encephalopathy patients. Sulfide is detoxified by a mitochondrial pathway that includes a sulfur dioxygenase. Sulfur dioxygenase activity was absent in Ethe1(-/-) mice, whereas it was markedly increased by ETHE1 overexpression in HeLa cells and Escherichia coli. Therefore, ETHE1 is a mitochondrial sulfur dioxygenase involved in catabolism of sulfide that accumulates to toxic levels in ethylmalonic encephalopathy.
Engineered mitochondria in diseases: mechanisms, strategies, and applications.
Li M, Wu L, Si H, Wu Y, Liu Y, Zeng Y Signal Transduct Target Ther. 2025; 10(1):71.
PMID: 40025039 PMC: 11873319. DOI: 10.1038/s41392-024-02081-y.
Sun L, Liu X, Zhou L, Wang H, Lian C, Zhong Z Commun Biol. 2025; 8(1):46.
PMID: 39806046 PMC: 11729891. DOI: 10.1038/s42003-024-07382-0.
Essential role of sulfide oxidation in brain health and neurological disorders.
Kanemaru E, Ichinose F Pharmacol Ther. 2024; 266:108787.
PMID: 39719173 PMC: 11806942. DOI: 10.1016/j.pharmthera.2024.108787.
Glanzel N, da Rosa-Junior N, Signori M, de Andrade Silveira J, Pinheiro C, Marcuzzo M Metab Brain Dis. 2024; 40(1):73.
PMID: 39704910 DOI: 10.1007/s11011-024-01510-9.
Jia G, Li H, Gan H, Wang J, Zhu Z, Wang Y Antioxidants (Basel). 2024; 13(11).
PMID: 39594544 PMC: 11591423. DOI: 10.3390/antiox13111402.